uMotif partnering with Novartis and IQVIA on NHS Cancer Vanguard project

London, UK – April 4, 2018. We’re excited to be partnering with both Novartis and IQVIA on an exciting project with The Christie National Cancer Vanguard site. Patient experiences of their care will be captured using our platform and will be used to support the improvement of our services in the future.

This work follows on from the deployment of the uMotif platform in colorectal cancer at the Christie which was proven successful in a poster presentation a the BOPA conference in October 2017.

Find out more here.